Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 13/20 | 0.64 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.62 |
| ▸ | MAOA | P21397 | 5/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | CA12 | O43570 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 1/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | CA3 | P07451 | 1/20 | 0.60 |
| ▸ | CA4 | P22748 | 1/20 | 0.60 |
| ▸ | CA6 | P23280 | 1/20 | 0.60 |
| ▸ | CA7 | P43166 | 1/20 | 0.60 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | CA9 | Q16790 | 1/20 | 0.60 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.60 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 3/20 | 0.57 |
| ▸ | BCHE | P06276 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29066609 | 0.84 | SLC16A3 (0.70) | MAOBSLC16A3MAOAMEN1NPC1 | |
| SCHEMBL1284982 | 0.82 | GPR55 (0.62) | MAOBSLC16A3MAOAMEN1NPC1 | |
| SCHEMBL1285503 | 0.82 | MAOB (0.49) | MAOBSLC16A3MAOAMEN1NPC1 | |
| SCHEMBL1285501 | 0.82 | MAOB (0.49) | MAOBSLC16A3MAOAMEN1NPC1 | |
| SCHEMBL1284769 | 0.79 | MAOB (0.57) | MAOBMAOAMEN1NPC1CA12 | |
| SCHEMBL4648135 | 0.79 | SLC16A3 (0.66) | MAOBSLC16A3MAOAMEN1NPC1 | |
| SCHEMBL22148003 | 0.78 | MAOB (1.00) | MAOBSLC16A3MAOACA12CA1 | |
| SCHEMBL93260 | 0.77 | SLC16A3 (1.00) | MAOBSLC16A3MAOAMEN1NPC1 | |
| SCHEMBL104995 | 0.76 | AR (0.67) | MAOBSLC16A3MAOAMEN1NPC1 | |
| SCHEMBL1093778 | 0.76 | MAOB (0.72) | MAOBSLC16A3MAOAMEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8383843-B2 | Method for preparing a coumarin compound, chromene compound, and method for preparing a chromene compound | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2013-02-26 | — | — | US | disclosed |
| US-20120088923-A1 | METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088923-A1 | METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND | CYP3A7, CYP2A7, F7 | MAOB 327/4885SLC16A3 4578/4885MAOA 428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.